Evado signs distribution deal
Monday, 14 April, 2008
Specialist life science training, quality assurance and regulatory compliance company SeerPharma has signed a re-seller agreement with Evado, a division of Australian company Invision IT Systems.
SeerPharma will distribute Evado's new web-based enterprise pre-clinical, clinical and mobile software modules in the SE Asian region. SeerPharma will also offer Evado as a software-as-a-service (SaaS) application to its medical device, biotechnology and life science clients.
Evado is a form-based technology that replaces the paper-based case report forms with easy to customise templates that are suitable for drug or device trials.
"Evado was created to provide a simple, easy-to-use, economical alternative to expensive clinical trial software," Evado's CEO Jennie Anderson said.
"Evado helps speed up clinical trials and assists researchers in the development of new medical therapies and medical devices by reducing costs and by improving data accuracy thereby achieving quicker regulatory approvals and time to market."
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
